Show simple item record

dc.contributor.authorThiruthaneeswaran, Niluja
dc.contributor.authorBibby, Becky A
dc.contributor.authorYang, Lingjian
dc.contributor.authorHoskin, P J
dc.contributor.authorBristow, Robert G
dc.contributor.authorChoudhury, Ananya
dc.contributor.authorWest, Catharine M L
dc.date.accessioned2021-04-20T08:08:25Z
dc.date.available2021-04-20T08:08:25Z
dc.date.issued2021en
dc.identifier.citationThiruthaneeswaran N, Bibby BAS, Yang L, Hoskin PJ, Bristow RG, Choudhury A, et al. Lost in application: Measuring hypoxia for radiotherapy optimisation. Eur J Cancer. 2021;148:260-76.en
dc.identifier.pmid33756422en
dc.identifier.doi10.1016/j.ejca.2021.01.039en
dc.identifier.urihttp://hdl.handle.net/10541/623961
dc.description.abstractThe history of radiotherapy is intertwined with research on hypoxia. There is level 1a evidence that giving hypoxia-targeting treatments with radiotherapy improves locoregional control and survival without compromising late side-effects. Despite coming in and out of vogue over decades, there is now an established role for hypoxia in driving molecular alterations promoting tumour progression and metastases. While tumour genomic complexity and immune profiling offer promise, there is a stronger evidence base for personalising radiotherapy based on hypoxia status. Despite this, there is only one phase III trial targeting hypoxia modification with full transcriptomic data available. There are no biomarkers in routine use for patients undergoing radiotherapy to aid management decisions, and a roadmap is needed to ensure consistency and provide a benchmark for progression to application. Gene expression signatures address past limitations of hypoxia biomarkers and could progress biologically optimised radiotherapy. Here, we review recent developments in generating hypoxia gene expression signatures and highlight progress addressing the challenges that must be overcome to pave the way for their clinical application.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/j.ejca.2021.01.039en
dc.titleLost in application: Measuring hypoxia for radiotherapy optimisationen
dc.typeArticleen
dc.contributor.departmentDivision of Cancer Sciences, The University of Manchester, Manchesteren
dc.identifier.journalEuropean Journal of Canceren
dc.description.noteen]
refterms.dateFOA2021-04-26T09:13:43Z


Files in this item

Thumbnail
Name:
33756422.pdf
Size:
1.123Mb
Format:
PDF
Description:
From UNPAYWALL

This item appears in the following Collection(s)

Show simple item record